Two‐decade battle with myasthenia gravis: A breakthrough case report on the long‐term success with eculizumab and ravulizumab treatment
Key Clinical Message This unique case of generalized myasthenia gravis shows sustained stability of a patient's condition for 3 years with eculizumab/ravulizumab treatment following 16 years of refractory disease. It highlights the long‐term effectiveness of C5 inhibitors in a real‐world setting, ai...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2024-11-01
|
| Seri Bilgileri: | Clinical Case Reports |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/ccr3.9547 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|